Dr. Christopher Chen
Claim this profileStanford Cancer Institute
Studies Colorectal Cancer
Studies Cancer
12 reported clinical trials
18 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
HER2 positive
2Cancer
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Christopher Chen is currently running
TNG462
for Solid Cancers
This trial is testing a new oral drug called TNG462 in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these cancer cells grow. The goal is to see if TNG462 can stop the cancer from growing and spreading.
Recruiting1 award Phase 1 & 2
RBS2418
for Cancer
This trial is testing a new drug called RBS2418, alone or with pembrolizumab, for patients with advanced tumors who haven't responded to other treatments. The drug works by boosting the body's natural defenses to better recognize and destroy cancer cells.
Recruiting1 award Phase 1
More about Christopher Chen
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Christopher Chen has experience with
- Tucatinib
- Trastuzumab
- Pembrolizumab
- ProstAtak® Immunotherapy
- Radiation Therapy
- Cerena™
Breakdown of trials Christopher Chen has run
Colorectal Cancer
Cancer
Solid Tumors
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Chen specialize in?
Christopher Chen focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Christopher Chen currently recruiting for clinical trials?
Yes, Christopher Chen is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Christopher Chen has studied deeply?
Yes, Christopher Chen has studied treatments such as Tucatinib, Trastuzumab, Pembrolizumab.
What is the best way to schedule an appointment with Christopher Chen?
Apply for one of the trials that Christopher Chen is conducting.
What is the office address of Christopher Chen?
The office of Christopher Chen is located at: Stanford Cancer Institute, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.